Home : DrugWatch : Sanctura : Newsfeeds

Sanctura - Newsfeeds

Family Doctor Meds may be to blame for excessive urination
My body and prostate are OK. I have high blood pressure, which is under control with Norvasc. I have tried all kinds of prescription medicine: Sanctura, Toviaz, Uroxatral, Elmiron, Hyomax, imipramine, amitriptyline. I am currently taking DDAVP. Nothing has worked.
Buy Glenmark For Short Term
Drug maker Glenmark Pharmaceuticals has announced that it has bagged US health regulator's sanction to market generic trospium tabs in the US market. Glenmark Pharma's US-based arm, Glenmark Generics Inc,
Buy Glenmark Pharma For Short Term
the generic version of Sanctura tabs by Allergan Inc.
Costco, Harry Winston, Melco Crown, Pride: U.S. Equity Preview
AGN US): The maker of the wrinkle smoother Botox said it expects an impairment charge of $340 million to $350 million related to its Sanctura franchise. Burger King Holdings Inc. (BKC US) rose 22 percent to $22.95.
Entry into a Material Definitive Agreement, Material Impairments, Other Events, Fina
the Company concluded that the intangible assets and a related prepaid royalty asset associated with the Sanctura® franchise (the "Sanctura® Assets"), which the Company acquired in connection with its October 2007 ...
CORRECTED - Allergan licenses drug for night-time ...
Allergan already sells a urology drug, called Sanctura, a once-daily drug to treat overactive bladder. That is a difficult-to-treat condition in which patients have a sudden and often unstoppable need to urinate. (Reporting by Ransdell Pierson ...
Indevus Pharmaceuticals, Inc. - Medical Equipment - Deals and ...
The company has four major product namely SANCTURA and SANCTURA XR for overactive bladder (OAB); VANTAS for advanced prostate cancer; SUPPRELIN LA for central precocious puberty (CPP), and DELATESTRYL for the treatment of hypogonadism.
Indevus Announces FDA Approval Of SANCTURA(R) XR
Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that SANCTURA(R) XR (trospium chloride extended release capsules) has been approved by the U.S. Food and Drug Administration (FDA). SANCTURA XR is indicated for the once daily treatment of ...
FDA To Review Xiaflex For Treatment Of Dupuytren's Contracture
Seeking approval to market trospium chloride 60mg capsules prior to the expiration of the patent ... FDA's Arthritis Advisory Committee has confirmed that it will review Auxilium's Xiaflex during an advisory committee hearing at the Holiday Inn in ...
Alkermes Announces Initiation Of Phase 2a Clinical Study Of ALKS 27 ...
ALKS 27 is an inhaled formulation of trospium based on Alkermes' proprietary AIR® pulmonary technology. This phase 2a study follows completion of a previous clinical study in patients with COPD, which showed that single doses of ALKS 27 demonstrated ...
Alkermes moves COPD drug to Phase 2a study
Alkermes Inc. , a Cambridge biotech company, has begun a Phase 2a clinical study of ALKS 27, an inhaled drug, in 24 patients with chronic obstructive pulmonary disease (COPD), company officials announced. ALKS 27 is an inhaled version of trospium ...
Local business briefs -- 7/16
Watson is seeking approval for trospium chloride extended release capsules. The patent is owned by Allergan Inc., and Allergan filed a lawsuit in U.S. District Court on Monday to block Watson's marketing of the drug before the ...
Madoff begins 150-year prison sentence
Allergan Inc. of Irvine sued Corona-based Watson Pharmaceuticals Inc., alleging infringement of a U.S. patent for Sanctura XR, a prescription medicine used to treat overactive bladder. Allergan, and business partners Endo Pharmaceuticals Solutions Inc ...
Watson Pharma Files ANDA For Generic Trospium Chloride Extended ...
The Corona, California-based company noted that trospium chloride extended-release capsules are the generic version of Allergan Inc.'s Sanctura XR product indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence ...
Supernus Pharmaceuticals raises $35M
In April 2008, the privately held company borrowed against its royalty payments from two marketed products that use its original technology, Oracea, an oral prescription treatment for inflammatory lesions, and Sanctura XR, a treatment for an ...
SuperNus Pharmaceuticals lands new $35M financing
Products formerly from Shire Laboratories, include: Adderall XR, Carbatrol and Equetro, which are marketed by Shire or its sub-licensees; and Oracea and Sanctura XR, which are marketed by Galderma and Allergan, respectively. Online: www.supurnus.com
Do you need a Sanctura attorney in Washington, DC? Contact one of our Sanctura attorneys in Washington, DC now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need A Sanctura Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need a Sanctura attorney in Washington, DC? Contact one of our Sanctura attorneys in Washington, DC now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Sanctura Case - Submit Your Information Below

Do you need legal assistance with your Sanctura case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Sanctura Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.